Increasing antituberculosis drug resistance in the United Kingdom: Analysis of national surveillance data

BMJ

Volumn 336, Issue 7655, 2008, Pages 1231-1234

  Kruijshaar, Michelle E ^a   Watson, John M ^a   Drobniewski, Francis ^b   Anderson, Charlotte ^a   Brown, Timothy J ^b   Magee, John G ^c   Smith, E Grace ^d   Story, Alistair ^a   Abubakar, Ibrahim ^a,e  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; AMINOSALICYLIC ACID; ETHIONAMIDE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; DRUG SENSITIVITY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; TUBERCULOSIS; DISEASE PREDISPOSITION; EPIDEMIOLOGY; MIDDLE AGED; UNITED KINGDOM;

ADULT; ANTITUBERCULAR AGENTS; DISEASE SUSCEPTIBILITY; EPIDEMIOLOGIC METHODS; ETHIONAMIDE; FEMALE; GREAT BRITAIN; HUMANS; ISONIAZID; MALE; MIDDLE AGED; P-AMINOSALICYLIC ACID; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 44849103998     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39546.573067.25     Document Type: Article

References (12)

1. Ruddy MC, Davies AP, Yates MD, Yates S, Balasegaram S, Drabu Y, et al. Outbreak of isoniazid resistant tuberculosis in north London. Thorax 2004;59:279-85.
2. WHO. Global tuberculosis control: surveillance, planning, financing. Geneva: World Health Organization, 2007.
3. Djuretic T, Herbert J, Drobniewski F, Yates M, Smith EG, Magee JG, et al. Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax 2002;57:477-82.
4. Irish C, Herbert J, Bennett D, Gilham C, Drobniewski F, Williams R, et al. Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6. BMJ 1999;318:497-8.
5. Kruijshaar ME, French CE, Anderson C, Abubakar I. Tuberculosis in the UK. Annual report on tuberculosis surveillance and control in the UK 2007. London: Health Protection Agency, 2007. www.hpa.org.uk/webw/ HPAweb&HPAwebStandard/HPAweb_C/1204100459636?p=1158945066450.
6. Rose AM, Watson JM, Graham C, Nunn AJ, Drobniewski F, Ormerod LP, et al. Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax 2001;56:173-9.
7. Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001;5:887-93.
8. Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 2006;61:158-63.
9. Moniruzzaman A, Elwood RK, Schulzer M, FitzGerald JM. A population-based study of risk factors for drug-resistant TB in British Columbia. Int J Tuberc Lung Dis 2006;10:631-8.
10. Glynn JR, Vynnycky E, Fine PE. Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol 1999;149:366-71.
11. EuroTB, National Coordinators for Tuberculosis Surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2005. Saint-Maurice, France: Institut de Veille Sanitaire, 2007.
12. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians, 2006.